Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 47

Allsaints Music Group streams $60m series B1

Oppo and Xiaomi have backed the streaming service leveraging blockchain for user content.

Sep 6, 2021

Olio obtains $43m in series B

Food-sharing platform Olio is eyeing foreign markets with series B funding raised from investors including Delivery Hero’s corporate venture capital unit.

Sep 6, 2021

Daily Deal Round Up: September 3, 2021

Versanis Bio secured $70 to commercialise a treatment licensed from Novartis, while Salesforce, Intel, Orange, Nike and Alphabet all celebrated exits.

Sep 3, 2021

Disc Medicine injects $90m in series B

The blood disease specialist secured a boost from Alexandria Real Estate Equities, Novo and Access Biotechnology to move two assets into phase 2 trials.

Sep 3, 2021

Corelight concentrates $75m into series D

The cybersecurity platform operator has achieved $160m of total funding through a series D round backed by Capital One and CrowdStrike.

Sep 3, 2021

Hefei Sineva assembles $93m round

The smart equipment manufacturer looks to integrate AI into its products following cash supplied by Ping An and Tianma Microelectronics.

Sep 2, 2021

Vice grips $85m from existing investors

Disney, A&E Networks and WPP-backed Vice Media has secured new funding in lieu of an anticipated reverse merger.

Sep 2, 2021

Gatik drives to $85m series B haul

Koch Industries is among the investors backing the autonomous short-haul provider as hits more than $114m in total funding.

Sep 2, 2021

Peak decides on $75m series C

SoftBank has thrown its weight behind the business intelligence software producer, which has now raised $119m altogether.

Sep 1, 2021

Daily Deal Round Up: August 31, 2021

Genomics care provider Genome Medical closed a $60m round backed by several corporates while brokerage software producer Alpaca secured $50m.

Aug 31, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here